[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)].
Nagano
Nobuo
N
nobuo.nagano@kyowa-kirin.co.jp
Kawata
Takehisa
T
Wada
Michihito
M
D000494:Allosteric Regulation / Q000502:physiology; D000818:Animals; D000069449:Cinacalcet; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D009281:Naphthalenes / Q000494:pharmacology* / Q000627:therapeutic use*; D010280:Parathyroid Glands / Q000187:drug effects*; D051381:Rats; D044169:Receptors, Calcium-Sensing / Q000187:drug effects*; D006435:Renal Dialysis
D009281:Naphthalenes; D044169:Receptors, Calcium-Sensing; D000069449:Cinacalcet